TR200000928T2 - Yeni kombinasyon. - Google Patents

Yeni kombinasyon.

Info

Publication number
TR200000928T2
TR200000928T2 TR2000/00928T TR200000928T TR200000928T2 TR 200000928 T2 TR200000928 T2 TR 200000928T2 TR 2000/00928 T TR2000/00928 T TR 2000/00928T TR 200000928 T TR200000928 T TR 200000928T TR 200000928 T2 TR200000928 T2 TR 200000928T2
Authority
TR
Turkey
Prior art keywords
new combination
inhibitor
inflammatory
cyclooxygenase
administration
Prior art date
Application number
TR2000/00928T
Other languages
English (en)
Inventor
Hamley Peter
Tinker Alan
Original Assignee
Astrazeneca Uk Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Limited filed Critical Astrazeneca Uk Limited
Publication of TR200000928T2 publication Critical patent/TR200000928T2/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Bulus, uyarilmis nitrik oksit sintazinin bir önleyicisi ile siklooksigenaz-2'nin bir önleyicisinin iltihap ve iltihabik bozukluklarin tedavisi için birlikte uygulanmasiyla ilgilidir.
TR2000/00928T 1997-10-10 1998-10-05 Yeni kombinasyon. TR200000928T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703693A SE9703693D0 (sv) 1997-10-10 1997-10-10 Novel combination

Publications (1)

Publication Number Publication Date
TR200000928T2 true TR200000928T2 (tr) 2000-11-21

Family

ID=20408563

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00928T TR200000928T2 (tr) 1997-10-10 1998-10-05 Yeni kombinasyon.

Country Status (20)

Country Link
US (1) US6046191A (tr)
EP (1) EP1027052A1 (tr)
JP (1) JP2001519391A (tr)
KR (1) KR20010031017A (tr)
CN (1) CN1281362A (tr)
AU (1) AU9469398A (tr)
BR (1) BR9812753A (tr)
CA (1) CA2305141A1 (tr)
CZ (1) CZ20001272A3 (tr)
EE (1) EE200000192A (tr)
HU (1) HUP0003874A2 (tr)
IL (1) IL135248A0 (tr)
IS (1) IS5430A (tr)
MX (1) MXPA00003445A (tr)
NO (1) NO20001830L (tr)
PL (1) PL339769A1 (tr)
SE (1) SE9703693D0 (tr)
SK (1) SK4282000A3 (tr)
TR (1) TR200000928T2 (tr)
WO (1) WO1999018960A1 (tr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701304D0 (sv) * 1997-04-09 1997-04-09 Astra Pharma Prod Compounds
EE200100084A (xx) * 1998-08-11 2002-08-15 Pfizer Products Inc. NOS inhibiitorite uued farmatseutilised kasutusv�imalused
MXPA02006312A (es) 1999-12-23 2004-06-21 Nitromed Inc Inhibidores de ciclooxigenasa-2 nitrosilatados y nitrosados, composiciones y metodos para utilizarse.
GB0004153D0 (en) * 2000-02-23 2000-04-12 Astrazeneca Uk Ltd Novel use
US6800297B2 (en) * 2000-06-15 2004-10-05 Acusphere, Inc. Porous COX-2 inhibitor matrices and methods of manufacture thereof
US6589557B2 (en) * 2000-06-15 2003-07-08 Acusphere, Inc. Porous celecoxib matrices and methods of manufacture thereof
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
IN191090B (tr) * 2000-08-29 2003-09-20 Ranbanx Lab Ltd
WO2002017896A2 (en) * 2000-08-29 2002-03-07 Peter Van Patten Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid
US7012098B2 (en) * 2001-03-23 2006-03-14 Pharmacia Corporation Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
US20030035795A1 (en) * 2001-04-13 2003-02-20 Gardell Stephen J. Methods for treating or reducing the risk of pain and inflammatory disorders by administering inhibitors of activated thrombin activatable fibrinolysis inhibitor
US20020187187A1 (en) * 2001-04-21 2002-12-12 Toshimitsu Ohki Fast disintegrating meloxicam tablet
AR035700A1 (es) * 2001-05-08 2004-06-23 Astrazeneca Ab Derivados de arilheteroalquilamina, composicion farmaceutica, usos de estos derivados para la fabricacion de medicamentos, metodos de tratamiento, y proceso para la preparacion de estos derivados
US20030114418A1 (en) * 2001-08-14 2003-06-19 Pharmacia Corporation Method for the treatment and prevention of pain and inflammation with glucosamine and a cyclooxygenase-2 selective inhibitor and compositions therefor
WO2003035080A2 (en) * 2001-08-28 2003-05-01 Ranbaxy Laboratories Limited A process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
KR20050044459A (ko) * 2001-11-13 2005-05-12 파마시아 코포레이션 파레콕시브 등의 설폰아미드 선구약물의 경구 투여 형태
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
KR20050005410A (ko) * 2002-02-19 2005-01-13 파마시아 코포레이션 요실금 치료용으로서의 시클로옥시게나제 저해제 및항무스카린제의 용도
US7220749B2 (en) 2002-06-11 2007-05-22 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
CA2493156A1 (en) * 2002-07-29 2004-02-05 Nitromed, Inc. Cyclooxygenase-2 selective inhibitors, compositions and methods of use
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
SI1622630T1 (sl) * 2003-05-07 2012-12-31 Osteologix A/S Stroncijeva kombinacije za profilakso/zdravljenje patologij hrustanca in/ali kosti
JP4354984B2 (ja) * 2003-05-07 2009-10-28 オステオロジックス エイ/エス 水溶性ストロンチウム塩を用いる軟骨/骨症状の治療
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
CA2570503A1 (en) * 2004-06-17 2005-12-29 Osteologix A/S A method of improving the medical treatment of pain
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
JP2009510007A (ja) * 2005-09-30 2009-03-12 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む医薬調製
ES2537898T3 (es) 2005-10-25 2015-06-15 Shionogi & Co., Ltd. Derivados de aminotiazolidina y aminotetrahidrotiazepina como inhibidores de BACE 1
JP2007275193A (ja) * 2006-04-04 2007-10-25 Fujifilm Corp 光プローブおよび光断層画像化装置
GB0712287D0 (en) * 2007-06-22 2007-08-01 Ucl Business Plc Antimicrobial Conjugates
US20090317436A1 (en) * 2006-08-04 2009-12-24 Mike Wilson Computer devices and accessories
JP2010516679A (ja) * 2007-01-19 2010-05-20 マリンクロット インコーポレイテッド 診断用および治療用シクロオキシゲナーゼ−2結合リガンド
JP5383484B2 (ja) 2007-04-24 2014-01-08 塩野義製薬株式会社 環式基で置換されたアミノジヒドロチアジン誘導体
JP5383483B2 (ja) 2007-04-24 2014-01-08 塩野義製薬株式会社 アルツハイマー症治療用医薬組成物
DE102007049612A1 (de) * 2007-10-17 2009-06-10 Evonik Goldschmidt Gmbh Bioaktive Zusammensetzung für kosmetische Anwendungen
US8637504B2 (en) 2008-06-13 2014-01-28 Shionogi & Co., Ltd. Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity
JPWO2010047372A1 (ja) 2008-10-22 2012-03-22 塩野義製薬株式会社 Bace1阻害活性を有する2−アミノピリミジン−4−オンおよび2−アミノピリジン誘導体
CN102647971B (zh) 2009-10-12 2016-03-16 贝林格尔.英格海姆维特梅迪卡有限公司 用于包含美洛昔康的组合物的容器
BR112012013854A2 (pt) 2009-12-11 2019-09-24 Shionogi & Co derivados de oxazina.
AU2010347598B2 (en) 2010-03-03 2014-11-27 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
JP5816630B2 (ja) 2010-10-29 2015-11-18 塩野義製薬株式会社 ナフチリジン誘導体
WO2012057247A1 (ja) 2010-10-29 2012-05-03 塩野義製薬株式会社 縮合アミノジヒドロピリミジン誘導体
WO2012147763A1 (ja) 2011-04-26 2012-11-01 塩野義製薬株式会社 オキサジン誘導体およびそれを含有するbace1阻害剤
WO2014065434A1 (en) 2012-10-24 2014-05-01 Shionogi & Co., Ltd. Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2224563A1 (en) * 1995-06-12 1996-12-27 G.D. Searle & Co. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
DE69635048T2 (de) * 1995-06-12 2006-02-16 G.D. Searle & Co. Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
ES2183140T3 (es) * 1996-02-13 2003-03-16 Searle & Co Combinaciones, que tienen efectos inmunosupresores, que contienen un inhibidor de ciclooxigenasa-2 y un inhibidor de leucotrieno a4 hidrolasa.

Also Published As

Publication number Publication date
IS5430A (is) 2000-04-06
NO20001830D0 (no) 2000-04-07
PL339769A1 (en) 2001-01-02
SE9703693D0 (sv) 1997-10-10
CZ20001272A3 (cs) 2000-09-13
NO20001830L (no) 2000-05-10
WO1999018960A1 (en) 1999-04-22
CA2305141A1 (en) 1999-04-22
JP2001519391A (ja) 2001-10-23
AU9469398A (en) 1999-05-03
IL135248A0 (en) 2001-05-20
SK4282000A3 (en) 2001-01-18
EE200000192A (et) 2001-04-16
BR9812753A (pt) 2000-08-29
US6046191A (en) 2000-04-04
MXPA00003445A (es) 2001-06-01
CN1281362A (zh) 2001-01-24
EP1027052A1 (en) 2000-08-16
HUP0003874A2 (hu) 2001-05-28
KR20010031017A (ko) 2001-04-16

Similar Documents

Publication Publication Date Title
TR200000928T2 (tr) Yeni kombinasyon.
SE9802333D0 (sv) Novel combination
TR200000815T2 (tr) In vitro hematopoietik hücrelerin stimulasyonu.
TR200102499T2 (tr) Neoplazi tedavisinde bir kombinasyon terapisi olarak bir siklooksijenaz-2 inhibitörü ve bir veya daha fazla antineoplastik ajan kullanma yöntemi
TR200000009T2 (tr) Triazol bileşikleri ve bunların dopamin-D3-ligandları olarak kullanımları.
DE69501591T2 (de) Lactobazillusstämme menschlichen ursprungs, ihre zusammensetzung und deren verwendung
EA199800667A1 (ru) Новые фенантридины
TR200000740T2 (tr) Dişleri beyazlatmak için metod ve kompozisyonlar.
YU53899A (sh) Primena inhibitora ciklooksigenaze-2 u prevenciji kardiovaskularnih poremećaja
TR200102958T2 (tr) Siklooksijenaz-2 inhibitörleri olarak 4,5-diaril-3(2H)-furanon türevleri.
DE69840603D1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
DK0889886T5 (da) Hidtil ukendte, i 6-stilling substituerede phenanthridiner
TR199901917T2 (tr) 2-Amino-6-(2-ikame edilmis-4-fenoksi)-ikame edilmis piridinler
IT1285770B1 (it) Composti corticoidei
DE69703201T2 (de) Hydroxyamidinderivate verwendbar als stickoxidsynthese inhibitoren
DK1032414T3 (da) Kombination af inhibitor for angiotensinomdannende enzym med et diuretikum til behandling af forstyrrelser i mikrokredsløbet
TR199900505T2 (tr)
TR200000907T2 (tr) Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.
CY1107039T1 (el) Αναστολεις τριπεπτιδυλ πεπτιδασης
BR9804749A (pt) Tratamento de purido.
BR0012675A (pt) Uso de inibidores de il-18
ATE335824T1 (de) Isolierte luziferasen sowie deren verwendung
DE69810629D1 (de) Beta-alkoxyacrylate gegen malaria
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
ID27052A (id) Pengobatan arthritis dan keadaan-keadaan lain yang sekupa